Defibrillators are medical devices used to defibrillate or stabilize the heartbeat of an individual in a condition of arrhythmias (irregular heartbeat) and ventricular tachycardia (a heart rhythm disorder). Automated external defibrillators (AEDs) are used to revive someone from sudden cardiac arrest. AEDs are portable, life-saving devices used to treat people experiencing sudden cardiac arrest, a serious heart condition. Most cardiac arrests occur when the heart's electrical system malfunctions. Thus, with the increasing prevalence of cardiac disorders, such as stroke and heart attack, the demand for defibrillators is also increasing.
Market Statistics:
The global automated external defibrillator market was valued at US$ 717.5 Mn in 2021 and is forecast to reach a value of US$ 1,217.0 Mn by 2028 at a CAGR of 7.8% between 2022 and 2028.
North America held dominant position in the global automated external defibrillator market in 2020, accounting for 55.0% share in terms of volume, followed by Europe and Asia Pacific, respectively.
Figure 1. Global Automated External Defibrillator Market Share (%), by Region, 2022
To learn more about this report, Request sample copy
Recent Developments:
In April 2021, ZOLL Medical Corporation acquired Respicardia, Inc., the company has sought to expand in the area such as heart failure, with this acquisition, focused on cardiopulmonary resuscitation, such as defibrillators, AEDs, and LifeVest wearable defibrillators.
In June 2020, Royal Philips received the United States Food and Drug Administration (FDA) premarket approval for HeartStart FR3 and HeartStart FRx automated external defibrillators, and their supporting accessories, including batteries and pads.
In September 2019, Shenzhen Mindray launched BeneHeart C Series AED with new features and provides faster shock delivery to achieve better resuscitation outcomes for sudden cardiac arrest (SCA). It is now available in Europe and other selected countries.
Market Drivers:
Automated External Defibrillator Market Report Coverage
Report Coverage | Details | ||
---|---|---|---|
Base Year: | 2021 | Market Size in 2021: | US$ 715.5 Mn |
Historical Data for: | 2017 to 2020 | Forecast Period: | 2022 to 2028 |
Forecast Period 2022 to 2028 CAGR: | 7.8% | 2028 Value Projection: | US$ 1,217.0 Mn |
Geographies covered: |
|
||
Segments covered: |
|
||
Companies covered: |
CU Medical System Inc., ViVest Medical, BPL Medical Technologies Pvt. Ltd., Mediana Co. Ltd., Stryker Corporation, Schiller AG, Nihon Kohden Corporation, Koninklijke Philips NV, Asahi Kasei Corporation, and Shenzhen Mindray Bio-Medical Electronics Co. Ltd., among others |
||
Growth Drivers: |
|
||
Restraints & Challenges: |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Figure 2. Global Automated External Defibrillator Market Share (%), by Analysis Type, 2022
To learn more about this report, Request sample copy
Market Restraints:
Market Opportunities:
Market Trends/Key Takeaways:
Competitive Landscape:
Share
Share
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Select a License Type
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our ClientsUS Reciprocal Tax Impact Analysis On Automated External Defibrillator Market
Stay updated on tariff changes with expert insights and timely information